vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and Whitestone REIT (WSR). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $43.9M, roughly 1.9× Whitestone REIT). Whitestone REIT runs the higher net margin — 52.0% vs -38.1%, a 90.1% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 7.5%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 8.7%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

Whitestone REIT is a publicly traded real estate investment trust that acquires, owns, manages and redevelops open-air community shopping centers, primarily located in high-growth metropolitan areas across the southwestern and southeastern United States. Its property portfolio is largely anchored by daily necessity, service-focused retail tenants that cater to regular local consumer demand.

PRCT vs WSR — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.9× larger
PRCT
$83.1M
$43.9M
WSR
Growing faster (revenue YoY)
PRCT
PRCT
+12.7% gap
PRCT
20.2%
7.5%
WSR
Higher net margin
WSR
WSR
90.1% more per $
WSR
52.0%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
8.7%
WSR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
PRCT
PRCT
WSR
WSR
Revenue
$83.1M
$43.9M
Net Profit
$-31.6M
$22.8M
Gross Margin
64.9%
Operating Margin
-4.1%
53.0%
Net Margin
-38.1%
52.0%
Revenue YoY
20.2%
7.5%
Net Profit YoY
-27.9%
31.7%
EPS (diluted)
$-0.56
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
WSR
WSR
Q1 26
$83.1M
Q4 25
$76.4M
$43.9M
Q3 25
$83.3M
$41.0M
Q2 25
$79.2M
$37.9M
Q1 25
$69.2M
$38.0M
Q4 24
$68.2M
$40.8M
Q3 24
$58.4M
$38.6M
Q2 24
$53.4M
$37.6M
Net Profit
PRCT
PRCT
WSR
WSR
Q1 26
$-31.6M
Q4 25
$-29.8M
$22.8M
Q3 25
$-21.4M
$18.3M
Q2 25
$-19.6M
$5.1M
Q1 25
$-24.7M
$3.7M
Q4 24
$-18.9M
$17.3M
Q3 24
$-21.0M
$7.6M
Q2 24
$-25.6M
$2.6M
Gross Margin
PRCT
PRCT
WSR
WSR
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
PRCT
PRCT
WSR
WSR
Q1 26
-4.1%
Q4 25
-40.6%
53.0%
Q3 25
-27.8%
45.5%
Q2 25
-28.0%
13.8%
Q1 25
-39.7%
10.2%
Q4 24
-28.9%
43.3%
Q3 24
-38.4%
20.3%
Q2 24
-50.3%
7.2%
Net Margin
PRCT
PRCT
WSR
WSR
Q1 26
-38.1%
Q4 25
-39.1%
52.0%
Q3 25
-25.7%
44.7%
Q2 25
-24.7%
13.3%
Q1 25
-35.8%
9.7%
Q4 24
-27.6%
42.5%
Q3 24
-35.9%
19.7%
Q2 24
-48.0%
6.9%
EPS (diluted)
PRCT
PRCT
WSR
WSR
Q1 26
$-0.56
Q4 25
$-0.54
$0.43
Q3 25
$-0.38
$0.35
Q2 25
$-0.35
$0.10
Q1 25
$-0.45
$0.07
Q4 24
$-0.34
$0.34
Q3 24
$-0.40
$0.15
Q2 24
$-0.50
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
WSR
WSR
Cash + ST InvestmentsLiquidity on hand
$245.6M
$4.9M
Total DebtLower is stronger
$51.7M
$649.4M
Stockholders' EquityBook value
$347.7M
$458.1M
Total Assets
$487.1M
$1.2B
Debt / EquityLower = less leverage
0.15×
1.42×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
WSR
WSR
Q1 26
$245.6M
Q4 25
$286.5M
$4.9M
Q3 25
$294.3M
$6.8M
Q2 25
$302.7M
$5.3M
Q1 25
$316.2M
$5.6M
Q4 24
$333.7M
$5.2M
Q3 24
$196.8M
$2.5M
Q2 24
$214.1M
$3.2M
Total Debt
PRCT
PRCT
WSR
WSR
Q1 26
$51.7M
Q4 25
$51.6M
$649.4M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
$632.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
PRCT
PRCT
WSR
WSR
Q1 26
$347.7M
Q4 25
$365.9M
$458.1M
Q3 25
$380.3M
$439.5M
Q2 25
$385.8M
$427.5M
Q1 25
$389.2M
$431.0M
Q4 24
$402.2M
$438.2M
Q3 24
$241.2M
$419.5M
Q2 24
$251.8M
$418.3M
Total Assets
PRCT
PRCT
WSR
WSR
Q1 26
$487.1M
Q4 25
$508.1M
$1.2B
Q3 25
$511.5M
$1.1B
Q2 25
$513.1M
$1.2B
Q1 25
$519.4M
$1.1B
Q4 24
$534.0M
$1.1B
Q3 24
$374.1M
$1.1B
Q2 24
$374.4M
$1.1B
Debt / Equity
PRCT
PRCT
WSR
WSR
Q1 26
0.15×
Q4 25
0.14×
1.42×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
1.44×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRCT
PRCT
WSR
WSR
Operating Cash FlowLast quarter
$50.8M
Free Cash FlowOCF − Capex
$50.5M
FCF MarginFCF / Revenue
114.9%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
2.22×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRCT
PRCT
WSR
WSR
Q1 26
Q4 25
$-10.3M
$50.8M
Q3 25
$-6.6M
$18.0M
Q2 25
$-15.0M
$13.8M
Q1 25
$-17.0M
$3.1M
Q4 24
$-32.4M
$58.2M
Q3 24
$-18.8M
$16.4M
Q2 24
$-15.7M
$12.3M
Free Cash Flow
PRCT
PRCT
WSR
WSR
Q1 26
Q4 25
$-12.2M
$50.5M
Q3 25
$-9.5M
Q2 25
$-17.8M
Q1 25
$-18.8M
Q4 24
$-33.6M
$58.0M
Q3 24
$-19.0M
Q2 24
$-16.8M
FCF Margin
PRCT
PRCT
WSR
WSR
Q1 26
Q4 25
-15.9%
114.9%
Q3 25
-11.4%
Q2 25
-22.5%
Q1 25
-27.2%
Q4 24
-49.2%
142.1%
Q3 24
-32.6%
Q2 24
-31.4%
Capex Intensity
PRCT
PRCT
WSR
WSR
Q1 26
Q4 25
2.4%
0.7%
Q3 25
3.4%
Q2 25
3.5%
Q1 25
2.7%
Q4 24
1.7%
0.5%
Q3 24
0.4%
Q2 24
2.0%
Cash Conversion
PRCT
PRCT
WSR
WSR
Q1 26
Q4 25
2.22×
Q3 25
0.98×
Q2 25
2.74×
Q1 25
0.83×
Q4 24
3.36×
Q3 24
2.15×
Q2 24
4.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

WSR
WSR

Segment breakdown not available.

Related Comparisons